Extending a Bold vision for Longevity

Why Bold Capital's Sergey Young is launching a discrete longevity fund

After making a handful of longevity-related investments as a partner at Bold Capital, Sergey Young is seeking to invest about $100 million via the Longevity Vision Fund, a new vehicle dedicated solely to the field of life extension technologies.

Young told BioCentury the fund has raised

Read the full 459 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE